THRX

Theseus Pharmaceuticals (THRX)

Theseus Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:THRX
DateTimeSourceHeadlineSymbolCompany
05/19/20228:30AMPR Newswire (US)Theseus Pharmaceuticals to Participate in Upcoming Investor Conferences NASDAQ:THRXTheseus Pharmaceuticals Inc
05/18/20224:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:THRXTheseus Pharmaceuticals Inc
05/18/20224:25PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3) NASDAQ:THRXTheseus Pharmaceuticals Inc
05/18/20224:23PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:THRXTheseus Pharmaceuticals Inc
05/18/20228:30AMPR Newswire (US)Theseus Pharmaceuticals Appoints Don Hayden to Board of Directors NASDAQ:THRXTheseus Pharmaceuticals Inc
05/14/202212:18AMTipRanksSVB Securities Thinks Theseus Pharmaceuticals’ Stock is Going to Recover NASDAQ:THRXTheseus Pharmaceuticals Inc
05/12/20227:16AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:THRXTheseus Pharmaceuticals Inc
05/12/20227:00AMPR Newswire (US)Theseus Pharmaceuticals Announces Business Highlights and Reports First Quarter 2022 Financial Results NASDAQ:THRXTheseus Pharmaceuticals Inc
04/25/20224:35PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:THRXTheseus Pharmaceuticals Inc
04/25/20224:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a) NASDAQ:THRXTheseus Pharmaceuticals Inc
04/08/20221:00PMPR Newswire (US)Theseus Pharmaceuticals Announces Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting NASDAQ:THRXTheseus Pharmaceuticals Inc
04/05/20228:30AMPR Newswire (US)Theseus Pharmaceuticals to Participate Virtually in Needham Healthcare Conference NASDAQ:THRXTheseus Pharmaceuticals Inc
03/11/202210:55PMTipRanksLeerink Partners Thinks Theseus Pharmaceuticals’ Stock is Going to Recover NASDAQ:THRXTheseus Pharmaceuticals Inc
03/10/20227:49AMSeeking AlphaTheseus Pharmaceuticals GAAP EPS of -$0.24 beats by $0.04 NASDAQ:THRXTheseus Pharmaceuticals Inc
03/10/20227:24AMEdgar (US Regulatory)Annual Report (10-k) NASDAQ:THRXTheseus Pharmaceuticals Inc
03/10/20227:16AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:THRXTheseus Pharmaceuticals Inc
03/10/20227:00AMPR Newswire (US)Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results NASDAQ:THRXTheseus Pharmaceuticals Inc
03/08/20225:01PMPR Newswire (US)Theseus Pharmaceuticals to Present Preclinical Data Characterizing Next-Generation Epidermal Growth Factor Receptor (EGFR) Inhibitors at the 2022 American Association for Cancer Research (AACR) Annual Meeting NASDAQ:THRXTheseus Pharmaceuticals Inc
02/09/202210:04AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a) NASDAQ:THRXTheseus Pharmaceuticals Inc
02/09/20227:30AMPR Newswire (US)Theseus Pharmaceuticals to Participate Virtually in SVB Leerink Global Healthcare Conference NASDAQ:THRXTheseus Pharmaceuticals Inc
02/02/20229:46AMSeeking AlphaTheseus' THE-630 gets FDA orphan drug status for gastrointestinal stromal tumors NASDAQ:THRXTheseus Pharmaceuticals Inc
02/02/20228:12AMDow Jones NewsTheseus Gets FDA Orphan Designation for THE-630 in Advanced GIST NASDAQ:THRXTheseus Pharmaceuticals Inc
02/02/20227:30AMPR Newswire (US)Theseus Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for THE-630 for the Treatment of Advanced Gastrointestinal Stromal Tumors (GIST) NASDAQ:THRXTheseus Pharmaceuticals Inc
01/14/202211:25AMSeeking AlphaTheseus Pharma gains after insider purchase NASDAQ:THRXTheseus Pharmaceuticals Inc
01/10/20227:17AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:THRXTheseus Pharmaceuticals Inc
12/23/202112:30PMSeeking AlphaZEV, GP and NES among mid-day movers NASDAQ:THRXTheseus Pharmaceuticals Inc
12/23/202111:03AMSeeking AlphaTheseus Pharmaceuticals up 24% following two insider buys NASDAQ:THRXTheseus Pharmaceuticals Inc
12/22/20216:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:THRXTheseus Pharmaceuticals Inc
12/22/20216:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:THRXTheseus Pharmaceuticals Inc
12/17/20218:00AMPR Newswire (US)Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies NASDAQ:THRXTheseus Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:THRX
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220523 13:42:31